• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室检测补体和补体调节蛋白紊乱。

Laboratory tests for disorders of complement and complement regulatory proteins.

机构信息

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, 02114.

出版信息

Am J Hematol. 2015 Dec;90(12):1180-6. doi: 10.1002/ajh.24209.

DOI:10.1002/ajh.24209
PMID:26437749
Abstract

The complement pathway is a cascade of proteases that is involved in immune surveillance and innate immunity, as well as adaptive immunity. Dysfunction of the complement cascade may be mediated by aberrations in the pathways of activation, complement regulatory proteins, or complement deficiencies, and has been linked to a number of hematologic disorders, including paroxysmal noctural hemoglobinuria (PNH), hereditary angioedema (HAE), and atypical hemolytic-uremic syndrome (aHUS). Here, current laboratory tests for disorders of the complement pathway are reviewed, and their utility and limitations in hematologic disorders and systemic diseases are discussed. Current therapeutic advances targeting the complement pathway in treatment of complement-mediated hematologic disorders are also reviewed.

摘要

补体途径是一系列蛋白酶,参与免疫监视和先天免疫以及适应性免疫。补体级联功能障碍可能由激活途径、补体调节蛋白或补体缺陷的异常介导,并与许多血液系统疾病有关,包括阵发性夜间血红蛋白尿症(PNH)、遗传性血管性水肿(HAE)和非典型溶血尿毒综合征(aHUS)。本文回顾了补体途径异常的当前实验室检测方法,并讨论了其在血液系统疾病和系统性疾病中的应用及局限性。本文还综述了针对补体介导的血液系统疾病治疗中补体途径的当前治疗进展。

相似文献

1
Laboratory tests for disorders of complement and complement regulatory proteins.实验室检测补体和补体调节蛋白紊乱。
Am J Hematol. 2015 Dec;90(12):1180-6. doi: 10.1002/ajh.24209.
2
Complementopathies.补体病
Blood Rev. 2017 Jul;31(4):213-223. doi: 10.1016/j.blre.2017.02.003. Epub 2017 Feb 6.
3
Diseases of complement dysregulation-an overview.补体调控异常相关疾病概述。
Semin Immunopathol. 2018 Jan;40(1):49-64. doi: 10.1007/s00281-017-0663-8. Epub 2018 Jan 11.
4
[Atypical hemolytic uremic syndrome caused by primary complement defects].[原发性补体缺陷所致非典型溶血尿毒综合征]
Orv Hetil. 2018 Jun;159(23):929-936. doi: 10.1556/650.2018.31044.
5
Clinical significance of complement deficiencies.补体缺陷的临床意义。
Ann N Y Acad Sci. 2009 Sep;1173:108-23. doi: 10.1111/j.1749-6632.2009.04633.x.
6
[Biological roles of complement and recent topics in clinical medicine].[补体的生物学作用及临床医学的最新话题]
Rinsho Byori. 2012 Aug;60(8):779-85.
7
Complement disorders and hereditary angioedema.补体系统紊乱与遗传性血管性水肿。
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S262-71. doi: 10.1016/j.jaci.2009.10.063.
8
Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management.补体缺陷和失调:病理生理学后果、现代分析和临床管理。
Mol Immunol. 2019 Oct;114:299-311. doi: 10.1016/j.molimm.2019.08.002. Epub 2019 Aug 14.
9
Complement the hemostatic system: an intimate relationship.补充止血系统:一种密切的关系。
Thromb Res. 2014 May;133 Suppl 2:S117-21. doi: 10.1016/S0049-3848(14)50020-5.
10
Modeling complement-driven diseases in transgenic mice: Values and limitations.在转基因小鼠中模拟补体驱动的疾病:价值与局限性。
Immunobiology. 2016 Oct;221(10):1080-90. doi: 10.1016/j.imbio.2016.06.007. Epub 2016 Jun 16.

引用本文的文献

1
The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential.补体系统与病原体之间的生死较量:清除机制、逃避策略及转化潜力
Virulence. 2025 Dec;16(1):2553781. doi: 10.1080/21505594.2025.2553781. Epub 2025 Sep 4.
2
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies.补体系统缺陷与髓系恶性肿瘤发病机制之间新的关联:补充还是损伤?
J Leukoc Biol. 2024 Nov 4;116(5):966-984. doi: 10.1093/jleuko/qiae130.
3
Complements and Their Role in Systemic Disorders.
补体及其在全身性疾病中的作用。
Cureus. 2024 Jan 26;16(1):e52991. doi: 10.7759/cureus.52991. eCollection 2024 Jan.
4
Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.用于癌症治疗的红细胞衍生材料:构建、分布及应用
Mater Today Bio. 2023 Dec 15;24:100913. doi: 10.1016/j.mtbio.2023.100913. eCollection 2024 Feb.
5
Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation-etiological and therapeutic issues.病例报告:由温抗体和冷抗体伴补体激活引起的自身免疫性溶血性贫血——病因及治疗问题
Front Pediatr. 2023 Sep 19;11:1217536. doi: 10.3389/fped.2023.1217536. eCollection 2023.
6
Thrombotic microangiopathies assessment: mind the complement.血栓性微血管病评估:关注补体。
Clin Kidney J. 2020 Nov 6;14(4):1055-1066. doi: 10.1093/ckj/sfaa195. eCollection 2021 Apr.
7
Deficiency of CFHR plasma proteins and autoantibody positive hemolytic uremic syndrome: treatment rationale, outcomes, and monitoring.CFHR血浆蛋白缺乏与自身抗体阳性溶血性尿毒症综合征:治疗原理、结果及监测
Pediatr Nephrol. 2021 Jun;36(6):1365-1375. doi: 10.1007/s00467-020-04652-x. Epub 2020 Jun 12.
8
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.欧洲免疫缺陷学会(ESID)和罕见原发性免疫缺陷、自身炎症和自身免疫性疾病欧洲参考网络(ERN RITA)补体指南:缺陷、诊断和管理。
J Clin Immunol. 2020 May;40(4):576-591. doi: 10.1007/s10875-020-00754-1. Epub 2020 Feb 17.
9
Preanalytical classical and alternative complement pathway activity loss.分析前经典和替代补体途径活性丧失。
Biochem Med (Zagreb). 2019 Oct 15;29(3):030701. doi: 10.11613/BM.2019.030701. Epub 2019 Aug 5.